Intellectual Property Notes

The Italian medicines agency AIFA opens a public consultation on the draft guidelines for the preparation of the dossier supporting a price and reimbursement application

Glaxo’s purple inhalers fail to get trade mark protection

The Unified Patent Court - on the move again?

Patent and Pharma Update, August 2020

Judicial Review – Strategies for Pharmaceutical Companies

In the latest episode of HSF's webinar series on the pharmaceutical sector, Andrew Lidbetter, Sanam Zulfiqar Khan, Mark Smyth and Lourdes Fraguas discuss …

UK's exit from the UPC now final

Where is the balance now? Preliminary injunctions in pharmaceutical patent proceedings in 2020 and beyond

Recent decisions of the Federal Court of Australia have significantly changed the way in which parties to pharmaceutical patent litigation should analyse …

The High Court of England & Wales maintains the status quo for Edwards’ PASCAL Transcatheter Valve Repair System when considering a stay of a final injunction pending appeal

Court of Appeal of England & Wales maintains no interim injunction for Neurim and Flynn against generic Circadin® – damages held to be an adequate remedy

CJEU rules that providing free samples of non-prescription drugs to pharmacists is permitted

UK Supreme Court in Regeneron v Kymab: technical contribution critical to determining sufficiency

Unsuccessful strike out of a quia timet infringement counterclaim